SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001539497-24-000590
Filing Date
2024-02-23
Accepted
2024-02-23 17:26:11
Documents
15
Period of Report
2024-02-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K n3936_x24-8k.htm   iXBRL 8-K 42768
2 AMENDMENT TO CONSULTING AGREEMENT BY AND BETWEEN THE COMPANY AND RICHARD A. FAIR exh10-1.htm EX-10.1 6903
  Complete submission text file 0001539497-24-000590.txt   228466

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE blcm-20240223.xsd EX-101.SCH 3015
4 XBRL LABEL FILE blcm-20240223_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE blcm-20240223_pre.xml EX-101.PRE 22359
16 EXTRACTED XBRL INSTANCE DOCUMENT n3936_x24-8k_htm.xml XML 8930
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 24672733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)